Numedico updates

Numedico is thrilled to announce a new collaboration with V3Bio, a company based in Malaysia developing some of the world’s most innovative technology that focuses on wound management and infection control. Introducing Electrocyn, a series of products containing Hypochlorous acid or HOCl which is an antimicrobial component that is naturally produced in our own body to fight against invading pathogen in our body.

At Numedico our bigger vision is caring for the health and safety of communities around the world. We were heartbroken to hear about the devastating earthquake that hit Syria and Turkey.

What is a UTI? URICIL, is a product that can treat UTIs. It contains curcumin extracted from turmeric, a powerful antioxidant that fights illness and lowers its incidence. Click to find out more.

Microgravity research can provide powerful insights into fundamental and applied scientific investigations that are especially beneficial for researchers. and plants to extended space missions. Various industries benefit from the study as well, like Tax benefits, next-generation apparatus for experiments, more Effective Drug Encapsulation at low cost, and a reputation in the community.

November 14 is World Diabetes Day, and we'd like to use this opportunity to acknowledge this disease as it is one of the world's deadliest. In November 2021, Numedico founder Neville Calvert was diagnosed with Type 2 Diabetes, and it came as a complete shock as he did not have diabetes previously. It is Neville's combination of his passion for the healthcare sector and his own health experiences that drive what we do here at Numedico. 

Numedico has signed a global distribution partnership with UAE-based leading medical devices distributor PBC Medicals L.L.C The partnership, worth US$5.5 million dollars over the next two years, will see Numedico distribute their ClickZip™ Safety Syringe technology into these global markets.

Numedico Science Pty Ltd, a subsidiary of Numedico Technologies Pty Ltd, has committed to a collaborative partnership with space medtech start-up ResearchSat to explore and expand the development of novel drug delivery methods and therapeutics.

Numedico Technologies Pty Ltd (Numedico) and Omikron Group Ltd (OGL) are pleased to announce the completion and settlement of the acquisition of the global ClickZip assets and Omikron business

Challenging the status quo and innovating through safety and transparency, Numedico Technologies continues to drive innovation in the medical devices space. It has yet again been awarded as a positive disruptor in the industry by the global magazine CEO VIEWS.

It is with pleasure that we can announce that Numedico Technologies has been nominated as a winner in the 2020 Global Med-Tech Awards. Announced this week, Global Health and Pharma Magazine published the results of the 3rd annual MedTech Awards. This year the GHP News Medtech Awards 2020, celebrated those who have demonstrated an ability to innovate in this industry.